Por favor, use este identificador para citar o enlazar este ítem: https://repositorio.uca.edu.ar/handle/123456789/11638
Campo DC Valor Lengua/Idioma
dc.contributor.authorWang, Yuees
dc.contributor.authorQuan, Feies
dc.contributor.authorCao, Qiuhuaes
dc.contributor.authorLin, Yantinges
dc.contributor.authorYue, Chongxiues
dc.contributor.authorBi, Ranes
dc.contributor.authorCui, Xinmenges
dc.contributor.authorYang, Hongbaoes
dc.contributor.authorYang, Yonges
dc.contributor.authorBirnbaumer, Lutzes
dc.contributor.authorLi, Xianjinges
dc.contributor.authorGao, Xinghuaes
dc.date.accessioned2021-06-16T13:00:26Z-
dc.date.available2021-06-16T13:00:26Z-
dc.date.issued2021-
dc.identifier.citationWang, Y., et al. Quercetin alleviates acute kidney injury by inhibiting ferroptosis [en línea]. Journal of Advanced Research. 2021, 28. doi:10.1016/j.jare.2020.07.007. Disponible en: https://repositorio.uca.edu.ar/handle/123456789/11638es
dc.identifier.issn2090-1232-
dc.identifier.urihttps://repositorio.uca.edu.ar/handle/123456789/11638-
dc.description.abstractAbstract: Introduction: Ferroptosis is an iron-dependent regulated necrosis and has been proven to contribute to the progress of acute kidney injury (AKI). Quercetin (QCT), a natural flavonoid which is commonly found in numerous fruits and vegetables, has extensive pharmacological effects, such as anti-oxidant, antiinflammatory and anti-senescence effects. Objectives: This study aims to explain whether ferroptosis is a therapeutic strategy to AKI, and to explore the effect of QCT on AKI ferroptosis. Methods: NRK-52E cells and HK-2 cells were used for in vitro ferroptosis studies. Morphology of cells was detected by transmission electron microscopy. Lipid ROS was assayed using flow cytometry. In vivo, AKI was induced by ischemia–reperfusion (I/R) or folic acid (FA). To explore the molecular mechanisms, RNA-sequence analysis was performed. Transwell was used to detect macrophage migration. Results: We discovered that quercetin (QCT), a natural flavonoid, inhibited ferroptosis in renal proximal tubular epithelial cells. QCT blocked the typical morphologic changes of ferroptotic cells by reducing the levels of malondialdehyde (MDA) and lipid ROS and increasing the levels of glutathione (GSH). Moreover, QCT ameliorated AKI induced by I/R or FA. RNA-sequence analysis highlighted activation transcription factor 3 (ATF3), as it was the dominant one among all the 299 down-regulated genes by QCT. Knockdown of ATF3 could significantly increase the levels of SLC7A11, GPX4 and increased the cell viability. In addition, ferroptotic cells were found to be extremely pro-inflammatory by recruiting macrophages through CCL2, while QCT inhibited the chemotaxis of macrophages induced by ferroptosis in AKI. Conclusions: Collectively, these results identify QCT as a ferroptosis inhibitor and provide new therapeutic strategies for diseases related to ferroptosis.es
dc.formatapplication/pdfes
dc.language.isoenges
dc.publisherElsevieres
dc.rightsAcceso abierto*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.sourceJournal of Advanced Research Vol. 28, 2021es
dc.subjectFERROPTOSISes
dc.subjectMUERTE CELULAR REGULADAes
dc.subjectQUERCETINAes
dc.subjectLESION RENAL AGUDAes
dc.subjectMACROFAGOS DEL HIGADOes
dc.titleQuercetin alleviates acute kidney injury by inhibiting ferroptosises
dc.typeArtículoes
dc.identifier.doihttps://doi.org/10.1016/j.jare.2020.07.007-
dc.identifier.pmid33364059-
uca.disciplinaMEDICINAes
uca.issnrd1es
uca.affiliationFil: Wang, Yue. Center for New Drug Safety Evaluation and Research; Chinaes
uca.affiliationFil: Wang, Yue. China Pharmaceutical University. State Key Laboratory of Natural Medicines; Chinaes
uca.affiliationFil: Quan, Fei. Center for New Drug Safety Evaluation and Research; Chinaes
uca.affiliationFil: Quan, Fei. China Pharmaceutical University. State Key Laboratory of Natural Medicines; Chinaes
uca.affiliationFil: Cao, Qiuhua. Center for New Drug Safety Evaluation and Research; Chinaes
uca.affiliationFil: Lin, Yanting. Center for New Drug Safety Evaluation and Research; Chinaes
uca.affiliationFil: Yue, Chongxiu. Center for New Drug Safety Evaluation and Research; Chinaes
uca.affiliationFil: Bi, Ran. Center for New Drug Safety Evaluation and Research; Chinaes
uca.affiliationFil: Cui, Xinmeng. Center for New Drug Safety Evaluation and Research; Chinaes
uca.affiliationFil: Yang, Hongbao. China Pharmaceutical University. State Key Laboratory of Natural Medicines; Chinaes
uca.affiliationFil: Cao, Qiuhua. China Pharmaceutical University. State Key Laboratory of Natural Medicines; Chinaes
uca.affiliationFil: Lin, Yanting. China Pharmaceutical University. State Key Laboratory of Natural Medicines; Chinaes
uca.affiliationFil: Yue, Chongxiu. China Pharmaceutical University. State Key Laboratory of Natural Medicines; Chinaes
uca.affiliationFil: Bi, Ran. China Pharmaceutical University. State Key Laboratory of Natural Medicines; Chinaes
uca.affiliationFil: Cui, Xinmeng. China Pharmaceutical University. State Key Laboratory of Natural Medicines; Chinaes
uca.affiliationFil: Yang, Hongbao. China Pharmaceutical University. State Key Laboratory of Natural Medicines; Chinaes
uca.affiliationFil: Yang, Hongbao. Center for New Drug Safety Evaluation and Research; Chinaes
uca.affiliationFil: Yang, Yong. Center for New Drug Safety Evaluation and Research; Chinaes
uca.affiliationFil: Yang, Yong. China Pharmaceutical University. State Key Laboratory of Natural Medicines; Chinaes
uca.affiliationFil: Yang, Yong. Xuzhou Medical University. School of Pharmacy; Chinaes
uca.affiliationFil: Birnbaumer, Lutz. National Institute of Environmental Health Sciences. Neurobiology Laboratory; Estados Unidoses
uca.affiliationFil: Birnbaumer, Lutz. Pontificia Universidad Católica de Argentina. Facultad de Ciencias Médicas. Instituto de Investigaciones Biomédicas; Argentinaes
uca.affiliationFil: Li, Xianjing. Center for New Drug Safety Evaluation and Research; Chinaes
uca.affiliationFil: Li, Xianjing. China Pharmaceutical University. State Key Laboratory of Natural Medicines; Chinaes
uca.affiliationFil: Gao, Xinghua. Center for New Drug Safety Evaluation and Research; Chinaes
uca.affiliationFil: Gao, Xinghua. China Pharmaceutical University. State Key Laboratory of Natural Medicines; Chinaes
uca.versionpublishedVersiones
item.grantfulltextopen-
item.fulltextWith Fulltext-
item.languageiso639-1en-
crisitem.author.deptInstituto de Investigaciones Biomédicas - BIOMED-
crisitem.author.deptLaboratorio de Función y Farmacología de Canales Iónicos-
crisitem.author.deptConsejo Nacional de Investigaciones Científicas y Técnicas-
crisitem.author.deptFacultad de Ciencias Médicas-
crisitem.author.orcid0000-0002-0775-8661-
crisitem.author.parentorgFacultad de Ciencias Médicas-
crisitem.author.parentorgInstituto de Investigaciones Biomédicas - BIOMED-
crisitem.author.parentorgPontificia Universidad Católica Argentina-
Aparece en las colecciones: Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato
quercetin-alleviates-acute- kidney.pdf4,9 MBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro sencillo del ítem

Visualizaciones de página(s)

152
comprobado en 13-abr-2024

Descarga(s)

382
comprobado en 13-abr-2024

Google ScholarTM

Consultar


Altmetric


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons